CA2387702A1 - Gene prv-1 et son utilisation - Google Patents

Gene prv-1 et son utilisation Download PDF

Info

Publication number
CA2387702A1
CA2387702A1 CA002387702A CA2387702A CA2387702A1 CA 2387702 A1 CA2387702 A1 CA 2387702A1 CA 002387702 A CA002387702 A CA 002387702A CA 2387702 A CA2387702 A CA 2387702A CA 2387702 A1 CA2387702 A1 CA 2387702A1
Authority
CA
Canada
Prior art keywords
sequence
amino acids
nucleotides
prv
cells
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002387702A
Other languages
English (en)
Inventor
Heike Pahl
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Universitaetsklinikum Freiburg
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2387702A1 publication Critical patent/CA2387702A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/06—Antigout agents, e.g. antihyperuricemic or uricosuric agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10—Antioedematous agents; Diuretics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Oncology (AREA)
  • Molecular Biology (AREA)
  • Pain & Pain Management (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Neurosurgery (AREA)
  • Dermatology (AREA)
  • Cardiology (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Communicable Diseases (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Rheumatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Endocrinology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

L'invention concerne une séquence nucléotidique qui est codée pour la protéine PRV-1 et qui contient principalement la séquence ID N· 1. L'invention concerne également un procédé permettant de détecter ce gène de l'ARNm codé par ce gène et du polypeptide codé par ce gène.
CA002387702A 1999-09-30 2000-09-29 Gene prv-1 et son utilisation Abandoned CA2387702A1 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE19947010.3 1999-09-30
DE19947010A DE19947010A1 (de) 1999-09-30 1999-09-30 Das Gen PRV-1 und dessen Verwendung
PCT/EP2000/009594 WO2001023554A1 (fr) 1999-09-30 2000-09-29 Gene prv-1 et son utilisation

Publications (1)

Publication Number Publication Date
CA2387702A1 true CA2387702A1 (fr) 2001-04-05

Family

ID=7923937

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002387702A Abandoned CA2387702A1 (fr) 1999-09-30 2000-09-29 Gene prv-1 et son utilisation

Country Status (21)

Country Link
EP (1) EP1220920A1 (fr)
JP (1) JP2003510077A (fr)
KR (1) KR20020047191A (fr)
CN (1) CN1377408A (fr)
AU (1) AU1132401A (fr)
BG (1) BG106554A (fr)
BR (1) BR0014444A (fr)
CA (1) CA2387702A1 (fr)
CZ (1) CZ20021094A3 (fr)
DE (1) DE19947010A1 (fr)
EA (1) EA200200286A1 (fr)
EE (1) EE200200168A (fr)
HR (1) HRP20020269A2 (fr)
HU (1) HUP0203080A2 (fr)
IL (1) IL148770A0 (fr)
MX (1) MXPA02002800A (fr)
NO (1) NO20021498L (fr)
PL (1) PL354184A1 (fr)
SK (1) SK4262002A3 (fr)
WO (1) WO2001023554A1 (fr)
ZA (1) ZA200202379B (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL158599A0 (en) * 2003-10-26 2004-05-12 Yeda Res & Dev Methods of modulating hematopoiesis
AU2013266611B2 (en) 2012-05-21 2016-08-11 Genentech, Inc. Methods for improving safety of blood-brain barrier transport
CN111094547B (zh) * 2017-06-14 2024-02-09 德国亥姆霍兹慕尼黑中心健康与环境研究中心（有限公司） 用于纯化源自人胚胎干细胞的内胚层和胰腺内胚层细胞的方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU746956B2 (en) * 1997-05-06 2002-05-09 Zymogenetics Inc. Novel tumor antigens
IL139686A0 (en) * 1998-06-02 2002-02-10 Genentech Inc Secreted and transmembrane polypeptides and nucleic acids encoding the same
DE19849044A1 (de) * 1998-10-23 2000-04-27 Univ Ludwigs Albert Das Gen PRV-1 und dessen Verwendung
EP1141285A2 (fr) * 1998-12-16 2001-10-10 Genentech, Inc. Polypeptides secretes et transmembranaires et acides nucleiques codant pour ceux-ci

Also Published As

Publication number Publication date
HRP20020269A2 (en) 2003-06-30
PL354184A1 (en) 2003-12-29
BG106554A (bg) 2003-01-31
AU1132401A (en) 2001-04-30
DE19947010A1 (de) 2001-04-05
MXPA02002800A (es) 2002-07-22
CN1377408A (zh) 2002-10-30
SK4262002A3 (en) 2002-09-10
WO2001023554A1 (fr) 2001-04-05
ZA200202379B (en) 2003-10-29
CZ20021094A3 (cs) 2002-06-12
IL148770A0 (en) 2002-09-12
HUP0203080A2 (hu) 2002-12-28
NO20021498L (no) 2002-05-23
JP2003510077A (ja) 2003-03-18
EA200200286A1 (ru) 2002-12-26
KR20020047191A (ko) 2002-06-21
EP1220920A1 (fr) 2002-07-10
BR0014444A (pt) 2002-06-11
EE200200168A (et) 2003-04-15
NO20021498D0 (no) 2002-03-26

Similar Documents

Publication Publication Date Title
US7122654B2 (en) Vascular endothelial growth factor D (VEGF-D) antibodies and vectors, and methods of use
JP2002516103A (ja) インターロイキン２１およびインターロイキン２２
JP2001524814A (ja) ２８種類のヒト分泌タンパク質
JPH07107983A (ja) Ｊａｋキナーゼおよびサイトカインシグナル形質導入の調節
JP2001522239A (ja) ８７個のヒト分泌タンパク質
JP2002518010A (ja) ９４個のヒト分泌タンパク質
JPH07505139A (ja) 肝成長因子レセプター
JP2002533058A (ja) ９７個のヒト分泌タンパク質
JP2001521383A (ja) ２０個のヒト分泌タンパク質
US5858701A (en) DNA encoding an insulin receptor substrate
JP2002512521A (ja) ３２個のヒト分泌タンパク質
US20040072259A1 (en) Methods and products for manipulating hematopoietic stem cells
US6686153B1 (en) PRV-1 gene and the use thereof
CA2387702A1 (fr) Gene prv-1 et son utilisation
KR20030096447A (ko) 단축형 케모킨 베타-8
KR20010043090A (ko) 신규인 폴리펩티드, 그 폴리펩티드를 코드화하는 ｃＤＮＡ및 그 용도
JP2002502601A (ja) 樹状富化分泌リンパ球活性化分子
JP2000125888A (ja) シアロアドヘシンファミリ―メンバ――３
이현채 The Role of Adenylyl Cyclase-Associated Protein1 (CAP1) in Transendothelial Migration of Monocytes to Promote Chronic Inflammation
JP2002510192A (ja) １８６個のヒトの分泌タンパク質
CA2233367A1 (fr) Formes courtes de la chimiokine .beta.-8

Legal Events

Date Code Title Description
FZDC Discontinued application reinstated
FZDE Discontinued